Binek J, Hildebrand P, Beglinger C
Abteilung für Gastroenterologie, Kantonsspital St. Gallen.
Schweiz Med Wochenschr Suppl. 1996;79:44S-46S.
In this pilot study we investigated the value of a fourteen-day regimen with amoxicillin (1 g bid), ranitidine (300 mg/d) and ursodeoxycholic acid (300 mg tid) in eradicating Helicobacter pylori. 15 patients with non-ulcer dyspepsia (reactive CLO test, positive histology or 13C urea breath test) were enrolled. Helicobacter pylori was eradicated in 6 of 13 patients (13C urea breath test 4 weeks after the end of treatment). 2 patients were not followed up because of too short treatment (< 1 week). Only 5/15 patients had no side effects (33%). These results strongly suggest that ursodeoxycholic acid in this application regimen is not of use in eradicating Helicobacter pylori.
在这项初步研究中,我们调查了阿莫西林(1克,每日两次)、雷尼替丁(300毫克/天)和熊去氧胆酸(300毫克,每日三次)的十四天疗程在根除幽门螺杆菌方面的价值。纳入了15例非溃疡性消化不良患者(快速尿素酶试验阳性、组织学检查阳性或13C尿素呼气试验阳性)。13例患者中有6例幽门螺杆菌被根除(治疗结束后4周进行13C尿素呼气试验)。2例患者因治疗时间过短(<1周)未进行随访。仅5/15例患者无副作用(33%)。这些结果强烈表明,在此应用方案中,熊去氧胆酸对根除幽门螺杆菌无效。